Daniel Schneider MD, PhD
Assistant Professor of Internal Medicine
[email protected]

Available to mentor
Daniel Schneider MD, PhD
Assistant Professor
  • About
  • Qualifications
  • Recent Publications
    • About

    Dr. Schneider attended medical school at The University of Texas Health Sciences Center, Houston, TX and also obtained his Ph.D. in Biomedical Sciences from the University of Texas. Later, he completed an Internal Medicine residency at the University of Michigan, Ann Arbor, MI. Afterwards, he completed a fellowship in Pulmonary and Critical Care Medicine from the University of Michigan. In 2017, Dr. Schneider joined the University of Michigan Health System as a Clinical Lecturer in Internal Medicine.

    Qualifications
    • Fellow
      University of Michigan Medical School, Ann Arbor, 2017
    • Resident
      University of Michigan Medical School, Ann Arbor, 2013
    • Postdoctoral Research Fellow
      University of Texas Health Science Center at Dallas, Dallas, 2011
    Recent Publications See All Publications
    • Presentation
      Sleep Medicine Grand Rounds: Evaluation of a Veteran with Possible Deployment-Related Respiratory Disease.
      Schneider D. 2023 Mar;
    • Presentation
      Alveolar Macrophage Control of Viral Infection via Extracellular Vesicles.
      Schneider D. 2022 Jun;
    • Journal Article
      Alveolar macrophage-derived extracellular vesicles inhibit endosomal fusion of influenza virus.
      Schneider DJ, Smith KA, Latuszek CE, Wilke CA, Lyons DM, Penke LR, Speth JM, Marthi M, Swanson JA, Moore BB, Lauring AS, Peters-Golden M. EMBO J, 2020 Aug 17; 39 (16): e105057 DOI:10.15252/embj.2020105057
      PMID: 32643835
    • Presentation
      Alveolar Macrophage-Derived Extracellular Vesicles Internalized Within Alveolar Epithelial Cells Inhibit Fusion of Influenza and Endosomes in a pH- and Strain-Dependent Manner.
      Schneider D. 2020 Jun;
    • Proceeding / Abstract / Poster
      Mechanisms of Alveolar Macrophage Derived Extracellular Vesicle Defense Against Influenza Infection of Alveolar Epithelial Cells
      Schneider D, Smith K, Speth J, Wilke C, Lyons D, Penke LRK, Lauring A, Moore BB, Peters-Golden M. 2020 May; a7425 - a7425. DOI:10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7425
    • Journal Article
      Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics.
      Speth JM, Penke LR, Bazzill JD, Park KS, de Rubio RG, Schneider DJ, Ouchi H, Moon JJ, Keshamouni VG, Zemans RL, Lama VN, Arenberg DA, Peters-Golden M. JCI Insight, 2019 Oct 17; 4 (20): DOI:10.1172/jci.insight.131340
      PMID: 31619584
    • Presentation
      Alveolar macrophage-derived extracellular vesicles inhibit influenza infection of epithelial cells.
      Schneider D. 2019 Jul;
    • Additional Scholarship
      Educational Podcast Series.
      Schneider D. 2018 Aug;